120 related articles for article (PubMed ID: 12607874)
1. I-123 imaging after recombinant human thyroid-stimulating hormone to diagnose metastatic disease in an intubated patient with papillary thyroid cancer.
Fish SA; Alavi A; Mandel SJ
Clin Nucl Med; 2002 Dec; 27(12):895. PubMed ID: 12607874
[No Abstract] [Full Text] [Related]
2. Iodine-131 uptake in focal bronchiectasis mimicking metastatic thyroid cancer.
Song HC; Heo YJ; Kim SM; Bom HS
Clin Nucl Med; 2003 Apr; 28(4):351-2. PubMed ID: 12642729
[No Abstract] [Full Text] [Related]
3. Treatment of scan-negative, thyroglobulin-positive metastatic thyroid cancer using radioiodine 131I and recombinant human thyroid stimulating hormone.
Rudavsky AZ; Freeman LM
J Clin Endocrinol Metab; 1997 Jan; 82(1):11-4. PubMed ID: 8989223
[No Abstract] [Full Text] [Related]
4. Faster radioiodine washout in the treatment of pulmonary metastases of papillary thyroid cancer prepared with recombinant human thyroid-stimulating hormone.
Hung GU; Ho M; Kao CH
Clin Nucl Med; 2009 May; 34(5):316-7. PubMed ID: 19387216
[No Abstract] [Full Text] [Related]
5. Recombinant humane thyrotropin (rhtSH) a new aid in the diagnosis and treatment of thyroid carcinoma with radio-iodine.
Brans B; Gemmel F; De Winter O; Fiers T; De Roose J; Vermeersch H; Rubens R; Kaufman JM; Dierckx RA
Acta Clin Belg; 2001; 56(5):316-20. PubMed ID: 11770226
[TBL] [Abstract][Full Text] [Related]
6. Metastatic parotid tumor: a rare presentation for papillary carcinoma of thyroid.
Malhotra G; Nair N; Awasare S; Baghel NS
Clin Nucl Med; 2007 Jun; 32(6):488-90. PubMed ID: 17515766
[No Abstract] [Full Text] [Related]
7. Thyroid carcinoma: iodine-131-negative whole-body scan reverses to positive after a combination of thyrogen stimulation and withdrawal.
Kasner DL; Spieth ME; Starkman ME; Zdor-North D
Clin Nucl Med; 2002 Nov; 27(11):772-80. PubMed ID: 12394123
[TBL] [Abstract][Full Text] [Related]
8. Inflammatory diseases of the lung causing false-positive 131iodine whole body scans in the evaluation of papillary thyroid carcinoma. Two case reports.
Pina JS; Meyer CA; Billingsley JL; Matlock JP; Horan MP; Knodel DH
Chest; 1996 Aug; 110(2):565-7. PubMed ID: 8697869
[TBL] [Abstract][Full Text] [Related]
9. Preoperative scintigraphic visualization of lymph nodes and pulmonary metastases from papillary thyroid carcinoma.
Boughattas S; Hassine H; Arifa N; Chatti K; Degdegui M; Abdelkefi M; Essabbah H
Ann Nucl Med; 2004 Feb; 18(1):59-62. PubMed ID: 15072185
[TBL] [Abstract][Full Text] [Related]
10. Metastatic papillary thyroid carcinoma with normal serum thyroglobulin level.
Miller JH; Marcus CS
Clin Nucl Med; 1988 Sep; 13(9):652-3. PubMed ID: 3180613
[TBL] [Abstract][Full Text] [Related]
11. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
Lind P; Kohlfürst S
Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
[TBL] [Abstract][Full Text] [Related]
12. Inactive pulmonary tuberculosis mimicking metastasis from papillary thyroid carcinoma in diagnostic radioiodine whole-body scintigraphy.
Picolos MK; Habra M; Safdar A; Sarlis NJ
Thyroid; 2005 Sep; 15(9):1105-6. PubMed ID: 16187924
[No Abstract] [Full Text] [Related]
13. Retention of iodine-131 in respiratory tract in a patient with papillary thyroid carcinoma after radionuclide therapy: a rare false-positive finding.
Kienast O; Hofmann M; Ozer S; Dobrozemsky G; Dudczak R; Kurtaran A
Thyroid; 2003 May; 13(5):509-10. PubMed ID: 12855020
[No Abstract] [Full Text] [Related]
14. Esophageal diverticulum presenting as metastatic thyroid mass on iodine-131 scintigraphy.
Rashid K; Johns W; Chasse K; Walker M; Gupta SM
Clin Nucl Med; 2006 Jul; 31(7):405-8. PubMed ID: 16785810
[No Abstract] [Full Text] [Related]
15. Radioiodine dilution due to levothyroxine when using recombinant human thyroid-stimulating hormone: case report and discussion.
Klein HA
Clin Nucl Med; 2011 Oct; 36(10):899-903. PubMed ID: 21892041
[TBL] [Abstract][Full Text] [Related]
16. Diffuse radioiodine lung uptake in miliary thyroid carcinoma metastases.
Manier SM; Eggli D; Blue PW; Van Nostrand D
Clin Nucl Med; 1985 Dec; 10(12):872-3. PubMed ID: 4075685
[TBL] [Abstract][Full Text] [Related]
17. [Occult papillary thyroid carcinoma in thyroglossal cyst diagnosed by (18)FDG PET/CT scan].
Serrano Vicente J; Infante Torre JR; Rayo Madrid JI; García Bernardo L; Domínguez Grande ML; Durán Barquero C; Sánchez Sánchez R
Rev Esp Med Nucl Imagen Mol; 2012; 31(4):229-30. PubMed ID: 22980131
[No Abstract] [Full Text] [Related]
18. Timing of iodine-123 scintigraphy following use of recombinant human thyrotropin in differentiated thyroid carcinoma.
Yan W; Roach PJ; Bautovich GJ; Learoyd DL; Robinson BG
Clin Nucl Med; 2007 May; 32(5):375-7. PubMed ID: 17452866
[No Abstract] [Full Text] [Related]
19. [Diffuse sclerosing variant of papillary thyroid carcinoma].
Manrique Franco K; Domínguez Fernández R; Lara Capellán JI; Renedo Pascual G; Rovira Loscos A
Endocrinol Nutr; 2010 Dec; 57(10):500-2. PubMed ID: 20843752
[No Abstract] [Full Text] [Related]
20. Clinical value of different responses of serum thyroglobulin to recombinant human thyrotropin in the follow-up of patients with differentiated thyroid carcinoma.
David A; Blotta A; Rossi R; Zatelli MC; Bondanelli M; Roti E; Braverman LE; Busutti L; degli Uberti EC
Thyroid; 2005 Feb; 15(2):158-64. PubMed ID: 15753676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
